OA12381A - Orally administered controlled delivery system foronce daily administration of ciprofloxacin. - Google Patents
Orally administered controlled delivery system foronce daily administration of ciprofloxacin. Download PDFInfo
- Publication number
- OA12381A OA12381A OA1200200267A OA1200200267A OA12381A OA 12381 A OA12381 A OA 12381A OA 1200200267 A OA1200200267 A OA 1200200267A OA 1200200267 A OA1200200267 A OA 1200200267A OA 12381 A OA12381 A OA 12381A
- Authority
- OA
- OAPI
- Prior art keywords
- formulation
- ciprofloxacin
- agent
- xanthan gum
- tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51788700A | 2000-03-03 | 2000-03-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
OA12381A true OA12381A (en) | 2004-09-06 |
Family
ID=24061635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA1200200267A OA12381A (en) | 2000-03-03 | 2001-02-28 | Orally administered controlled delivery system foronce daily administration of ciprofloxacin. |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP1263409A1 (sh) |
JP (1) | JP2003525229A (sh) |
KR (1) | KR20030009374A (sh) |
CN (1) | CN1420763A (sh) |
AP (2) | AP1485A (sh) |
AR (1) | AR032614A1 (sh) |
AU (1) | AU3589701A (sh) |
BG (1) | BG107055A (sh) |
BR (1) | BR0108958A (sh) |
CA (1) | CA2400950A1 (sh) |
CZ (1) | CZ20022883A3 (sh) |
DO (1) | DOP2001000130A (sh) |
EA (1) | EA200200914A1 (sh) |
EC (1) | ECSP013952A (sh) |
EE (1) | EE200200497A (sh) |
GT (1) | GT200100033A (sh) |
HN (1) | HN2001000038A (sh) |
HR (1) | HRP20020715A2 (sh) |
HU (1) | HUP0204417A3 (sh) |
IL (1) | IL151553A0 (sh) |
IS (1) | IS6532A (sh) |
MX (1) | MXPA02008568A (sh) |
NO (1) | NO20024108L (sh) |
NZ (1) | NZ520927A (sh) |
OA (1) | OA12381A (sh) |
PE (1) | PE20011113A1 (sh) |
PL (1) | PL365071A1 (sh) |
SK (1) | SK12542002A3 (sh) |
WO (1) | WO2001064183A1 (sh) |
YU (1) | YU66202A (sh) |
ZA (1) | ZA200206764B (sh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0209265D0 (en) | 2002-04-23 | 2002-06-05 | Novartis Ag | Organic compounds |
US20030229101A1 (en) * | 2002-06-06 | 2003-12-11 | Sherman Bernard Charles | Tablets comprising ciprofloxacin hydrochloride |
DE10351448A1 (de) | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften |
DE602005007205D1 (de) | 2005-07-19 | 2008-07-10 | Ethypharm Sa | Gastroretentive Zusammensetzungen und Verfahren zur Herstellung |
DE602006012962D1 (de) * | 2006-07-19 | 2010-04-29 | Tabuk Pharmaceutical Mfg Co | Pharmazeutische Zubereitungen von Ciprofloxacin |
WO2016115253A1 (en) | 2015-01-14 | 2016-07-21 | The Regents Of The University Ofcolordo, A Body Corporate | Insulin mimotopes and methods of using the same |
CA3015400A1 (en) * | 2016-02-23 | 2017-08-31 | Matripharm International Inc. | Dual-rate release formulation with high drug loading |
CA3018727C (en) | 2016-03-24 | 2024-03-26 | The Regents Of The University Of Colorado, A Body Corporate | Methods of treating autoimmune disease |
US11052060B2 (en) | 2018-02-12 | 2021-07-06 | The Regents Of The University Of Colorado, A Body Corporate | Compounds and methods for treating autoimmunity |
US11013707B2 (en) | 2018-03-23 | 2021-05-25 | The Regents Of The University Of Colorado, A Body Corporate | Administration of oral methyldopa |
CN109806237A (zh) * | 2019-03-13 | 2019-05-28 | 悦康药业集团上海制药有限公司 | 一种乳酸环丙沙星泡腾片及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5096714A (en) * | 1988-06-28 | 1992-03-17 | Hauser-Kuhrts, Inc. | Prolonged release drug tablet formulations |
JPH0624959A (ja) * | 1991-10-04 | 1994-02-01 | Bayer Yakuhin Kk | 胃内浮遊型薬物徐放性固形製剤 |
DE4406424A1 (de) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandierbare Arzneiformen |
DE19839057A1 (de) * | 1998-08-28 | 2000-03-02 | Koch Berthold | Spülluft-Regler für eine Trockenvorrichtung für Druckluft |
EE200100153A (et) * | 1998-09-14 | 2002-06-17 | Ranbaxy Laboratories Limited | Kontrollitav ravimiväljutussüsteem ravimite suukaudseks manustamiseks, mis pakub ajalist ja ruumilist kontrolli |
-
2001
- 2001-02-28 BR BR0108958-7A patent/BR0108958A/pt not_active Withdrawn
- 2001-02-28 NZ NZ520927A patent/NZ520927A/xx unknown
- 2001-02-28 AU AU35897/01A patent/AU3589701A/en not_active Abandoned
- 2001-02-28 SK SK1254-2002A patent/SK12542002A3/sk unknown
- 2001-02-28 YU YU66202A patent/YU66202A/sh unknown
- 2001-02-28 EA EA200200914A patent/EA200200914A1/ru unknown
- 2001-02-28 CZ CZ20022883A patent/CZ20022883A3/cs unknown
- 2001-02-28 OA OA1200200267A patent/OA12381A/en unknown
- 2001-02-28 EP EP01908038A patent/EP1263409A1/en not_active Withdrawn
- 2001-02-28 AP APAP/P/2002/002627A patent/AP1485A/en active
- 2001-02-28 AR ARP010100957A patent/AR032614A1/es not_active Application Discontinuation
- 2001-02-28 AP APAP/P/2001/002084A patent/AP2001002084A0/en unknown
- 2001-02-28 IL IL15155301A patent/IL151553A0/xx unknown
- 2001-02-28 MX MXPA02008568A patent/MXPA02008568A/es unknown
- 2001-02-28 KR KR1020027011441A patent/KR20030009374A/ko not_active Application Discontinuation
- 2001-02-28 WO PCT/IB2001/000279 patent/WO2001064183A1/en not_active Application Discontinuation
- 2001-02-28 HU HU0204417A patent/HUP0204417A3/hu unknown
- 2001-02-28 CN CN01805998A patent/CN1420763A/zh active Pending
- 2001-02-28 PL PL01365071A patent/PL365071A1/xx not_active Application Discontinuation
- 2001-02-28 EE EEP200200497A patent/EE200200497A/xx unknown
- 2001-02-28 CA CA002400950A patent/CA2400950A1/en not_active Abandoned
- 2001-02-28 JP JP2001563081A patent/JP2003525229A/ja not_active Withdrawn
- 2001-03-01 EC EC2001003952A patent/ECSP013952A/es unknown
- 2001-03-01 GT GT200100033A patent/GT200100033A/es unknown
- 2001-03-01 PE PE2001000206A patent/PE20011113A1/es not_active Application Discontinuation
- 2001-03-02 DO DO2001000130A patent/DOP2001000130A/es unknown
- 2001-03-02 HN HN2001000038A patent/HN2001000038A/es unknown
-
2002
- 2002-08-23 ZA ZA200206764A patent/ZA200206764B/en unknown
- 2002-08-28 IS IS6532A patent/IS6532A/is unknown
- 2002-08-28 NO NO20024108A patent/NO20024108L/no unknown
- 2002-08-30 HR HRP20020715 patent/HRP20020715A2/hr not_active Application Discontinuation
- 2002-09-02 BG BG107055A patent/BG107055A/bg unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6261601B1 (en) | Orally administered controlled drug delivery system providing temporal and spatial control | |
EP1107741B1 (en) | Orally administered controlled drug delivery system providing temporal and spatial control | |
US6899896B2 (en) | Hydrogel-driven layered drug dosage form | |
CZ155498A3 (cs) | Farmaceutický prostředek s řízeným uvolňováním, způsob jeho výroby a použití polyethylenoxidu | |
AU2003282603A1 (en) | Gastro-retentive levodopa delivery form | |
JPH07558B2 (ja) | モピダモール製剤 | |
OA12381A (en) | Orally administered controlled delivery system foronce daily administration of ciprofloxacin. | |
JP2005508901A (ja) | 活性成分を徐放する剤形 | |
US20060147530A1 (en) | Sustained release compositions containing alfuzosin | |
AU2006201553A1 (en) | Orally administered controlled delivery system for once daily administration of ciprofloxacin | |
US20080206338A1 (en) | Controlled release formulations of an alpha-adrenergic receptor antagonist | |
WO2008050188A2 (en) | Sustained release pharmaceutical compositions of alfuzosin and process for preparation thereof | |
MC MK et al. | preparation thereof | |
GB2334212A (en) | Modified release matrix formulation for cefaclor and cephalexin |